{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:43:45Z","timestamp":1790207025046,"version":"4.1.0"},"reference-count":31,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2049,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2982.2010.01495.x","type":"journal-article","created":{"date-parts":[[2010,5,5]],"date-time":"2010-05-05T03:28:20Z","timestamp":1273030100000},"page":"e180-e191","source":"Crossref","is-referenced-by-count":26,"title":["Effect of otilonium bromide on contractile patterns in the human sigmoid colon"],"prefix":"10.1111","volume":"22","author":[{"given":"D.","family":"Gallego","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Aul\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Aleu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Rofes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mart\u00ed-ragu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Clav\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,1,21]]},"reference":[{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2036.2003.01456.x","article-title":"The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects","volume":"17","author":"Hungin","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"a2313","DOI":"10.1136\/bmj.a2313","article-title":"Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis","volume":"337","author":"Ford","year":"2008","journal-title":"BMJ"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1111\/j.1572-0241.2008.02066.x","article-title":"Contributions of pain sensitivity and colonic motility to IBS symptom severity and predominant bowel habits","volume":"103","author":"Kanazawa","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7326\/0003-4819-133-2-200007180-00013","article-title":"Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials","volume":"133","author":"Jailwala","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00044011-200727010-00002","article-title":"Irritable bowel syndrome","volume":"27","author":"Spinelli","year":"2007","journal-title":"Clin Drug Investig"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB6|cit6","first-page":"60","article-title":"Clinical and functional evaluation of the efficacy of otilonium bromide: a multicenter study in Italy","volume":"23","author":"Baldi","year":"1991","journal-title":"Ital J Gastroenterol"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB7|cit7","first-page":"392","article-title":"Octylonium bromide in the treatment of the irritable bowel syndrome: a clinical-functional study 1","volume":"39","author":"Baldi","year":"1992","journal-title":"Hepatogastroenterology"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1046\/j.1365-2036.1998.00397.x","article-title":"Otilonium bromide in irritable bowel syndrome: a double-blind, placebo-controlled, 15-week study 4","volume":"12","author":"Battaglia","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2036.2006.02938.x","article-title":"Systematic review: the efficacy of treatments for irritable bowel syndrome - a European perspective 17","volume":"24","author":"Tack","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.2174\/1381612043382972","article-title":"Quaternary ammonium derivatives as spasmolytics for irritable bowel syndrome","volume":"10","author":"Evangelista","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1476-5381.1996.tb15213.x","article-title":"Otilonium: a potent blocker of neuronal nicotinic ACh receptors in bovine chromaffin cells 25","volume":"117","author":"Gandia","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1006\/phrs.1998.0340","article-title":"Receptor binding profile of otilonium bromide 20","volume":"38","author":"Evangelista","year":"1998","journal-title":"Pharmacol Res"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/bjp.2008.332","article-title":"Effects of excitatory and inhibitory neurotransmission on motor patterns of human sigmoid colon in vitro","volume":"155","author":"Auli","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"G522","DOI":"10.1152\/ajpgi.00510.2007","article-title":"Purinergic and nitrergic junction potential in the human colon","volume":"295","author":"Gallego","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/sj.bjp.0704942","article-title":"The colon-selective spasmolytic otilonium bromide inhibits muscarinic M(3) receptor-coupled calcium signals in isolated human colonic crypts 1","volume":"137","author":"Lindqvist","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0016-5085(99)70349-5","article-title":"A mechanosensitive calcium channel in human intestinal smooth muscle cells 1","volume":"117","author":"Farrugia","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2982.2004.00518.x","article-title":"Otilonium bromide inhibits muscle contractions via L-type calcium channels in the rat colon 5","volume":"16","author":"Martin","year":"2004","journal-title":"Neurogastroenterol Motil"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2982.2004.00517.x","article-title":"Otilonium bromide inhibits calcium entry through L-type calcium channels in human intestinal smooth muscle 6","volume":"16","author":"Strege","year":"2004","journal-title":"Neurogastroenterol Motil"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s002280050302","article-title":"The clinical pharmacology of single doses of otilonium bromide in healthy volunteers","volume":"52","author":"Sutton","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12272-008-1129-2","article-title":"Oral bioavailability and enterohepatic recirculation of otilonium bromide in rats","volume":"31","author":"Shin","year":"2008","journal-title":"Arch Pharm Res"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB21|cit21","first-page":"5","article-title":"Autoradiographic localization of octylonium bromide binding sites in the rat gastrointestinal tract 17","volume":"311","author":"Amenta","year":"1991","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0090-9556(24)15142-2","article-title":"A distribution study with (14)C-otilonium bromide in the rat: evidence for selective tropism for large intestine after oral administration","volume":"28","author":"Evangelista","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1139\/y95-208","article-title":"Generation of slow wave type action potentials in the mouse small intestine involves a non-L-type calcium channel","volume":"73","author":"Malysz","year":"1995","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/PL00005370","article-title":"Antimuscarinic, calcium channel blocker and tachykinin NK2 receptor antagonist actions of otilonium bromide in the circular muscle of guinea-pig colon","volume":"359","author":"Santicioli","year":"1999","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0165-6147(98)01171-7","article-title":"Structural basis of drug binding to L Ca2\u2003+\u2003 channels","volume":"19","author":"Striessnig","year":"1998","journal-title":"Trends Pharmacol Sci"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"C1001","DOI":"10.1152\/ajpcell.00140.2002","article-title":"alpha(1C) (Ca(V)1.2) L-type calcium channel mediates mechanosensitive calcium regulation","volume":"283","author":"Lyford","year":"2002","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"C1666","DOI":"10.1152\/ajpcell.1994.267.6.C1666","article-title":"Sources of calcium utilized in cholinergic responses in canine colonic smooth muscle","volume":"267","author":"Sato","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/gast.2000.8552","article-title":"Gq-linked NK(2) receptors mediate neurally induced contraction of human sigmoid circular smooth muscle","volume":"119","author":"Cao","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"G545","DOI":"10.1152\/ajpgi.00122.2006","article-title":"Molecular, functional, and pharmacological targets for the development of gut promotility drugs","volume":"291","author":"Sarna","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0016-5085(85)90513-X","article-title":"Electrophysiologic control of motility in the human colon","volume":"88","author":"Huizinga","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2982.2010.01495.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"G629","DOI":"10.1152\/ajpgi.2001.280.4.G629","article-title":"Ambulatory 24-h colonic manometry in healthy humans","volume":"280","author":"Rao","year":"2001","journal-title":"Am J Physiol Gastrointest Liver Physiol"}],"container-title":["Neurogastroenterology &amp; Motility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2982.2010.01495.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2982.2010.01495.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T14:59:12Z","timestamp":1740063552000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2982.2010.01495.x"}},"subtitle":["Otilonium bromide inhibits human sigmoid motility"],"short-title":[],"issued":{"date-parts":[[2010,1,21]]},"references-count":31,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2982.2010.01495.x","relation":{},"ISSN":["1350-1925","1365-2982"],"issn-type":[{"value":"1350-1925","type":"print"},{"value":"1365-2982","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,21]]}}}